Andrew Dahl
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Andrew M.
Dahl is currently Chief Accounting Officer & SVP-Controller at Edwards Lifesciences Corp.
since 2024.
Mr. Dahl completed undergraduate studies at the University of San Diego.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/05/2026 | 15.334 ( 0 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EDWARDS LIFESCIENCES CORPORATION | Comptroller/Controller/Auditor | 01/02/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Edwards Lifesciences Corp.
Edwards Lifesciences Corp. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets products to treat late-stage cardiovascular disease | Health Technology |
University of San Diego
University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.